Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bayesian optimized propofol target-controlled infusion
2013-003909-26Phase 4Active
- Sponsor
- University Medical Center Groningen
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of propofol, sponsored by University Medical Center Groningen. Primary endpoint: Median absolute prediction error ratio. Started Oct 2013; status: active.
02
Drugs
propofol
Beyond the preview
Go deeper on 2013-003909-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003909-26.